Specific Immune Globulin Therapy for Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants: Not What We Hoped for!

Journal of Pediatrics

Volumn 151, Issue 3, 2007, Pages 232-234

  de la Morena, M Teresa ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; DEFENSIN; IMMUNOGLOBULIN;

CANDIDA ALBICANS; CHILD; CLINICAL TRIAL; COMORBIDITY; EDITORIAL; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SAMPLE SIZE; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; VERY LOW BIRTH WEIGHT;

CROSS INFECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; SEPSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 34548051131     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.06.031     Document Type: Editorial

References (19)

1. Callaghan W.M., MacDorman M.F., Rasmussen S.A., Qin C., and Lackritz E.M. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 118 (2006) 1566-1573
2. DeJonge M., Bloom B.D., et al. Phase III, randomized, double-blind, placebo-controlled multi-center clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal sepsis in premature infants. J Pediatr 151 (2007) 260-265
3. Stoll B.J., and Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 27 (2003) 293-301
4. Stoll B.J., Gordon T., Korones S.B., Shankaran S., Tyson J.E., Bauer C.R., et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 129 (1996) 63-71
5. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110 Pt 1 (2002) 285-291
6. In: Behrman R.E., and Butler A.S. (Eds). Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Board on Health Science Policy, Institute of Medicine. Preterm Births: Causes, Consequences, and Prevention (2006). http://www.iom.edu/object.file/Master/35/975/pretermbirth.pdf Brief Report July. http://www.iom.edu/object.file/Master/35/975/pretermbirth.pdf. Accessed August 8s, 2007
7. Baker C.J., Melish M.E., Hall R.T., Casto D.T., Vasan U., and Givner L.B. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med 327 (1992) 213-219
8. Weisman L.E., Stoll B.J., Kueser T.J., Rubio T.T., Frank C.G., Heiman H.S., et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 125 Pt 1 (1994) 922-930
9. Fanaroff A.A., Korones S.B., Wright L.L., Wright E.C., Poland R.L., Bauer C.B., et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330 (1994) 1107-1113
10. Ohlsson A., and Lacy J.B. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 1 (2004) CD001239
11. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99 (1997) 93-99
12. Bloom B., Schelonka R., Kueser T., Walker W., Jung E., Kaufman D., et al. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J 24 (2005) 858-866
13. Bona C. Neonatal immunity. In: Rose N.R. (Ed). Contemporary immunology (2005), Humana Press, Totowa, NJ 1-389
14. Ballow M., Cates K.L., Rowe J.C., Goetz C., and Desbonnet C. Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 20 (1986) 899-904
15. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 5439 (1999) 525-528
16. Yoshio H., Tollin M., Gudmundsson G.H., Lagercrantz H., Jornvall H., Marchini G., et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 53 (2003) 211-216
17. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
18. Murakami M., Ohtake T., Dorschner R.A., Schittek B., Garbe C., and Gallo R.L. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119 (2002) 1090-1095
19. Komatsuzawa H., Ouhara K., Yamada S., Fujiwara T., Sayama K., Hashimoto K., et al. Innate defenses against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol 208 (2006) 249-260